EMProS-Bio Overview

  • Founded
  • 2017
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

EMProS-Bio General Information


Provider of molecular diagnostics services intended for migraine headache and other types of neuroinflammatory diseases. The company's services offers test which are designed to permit appropriate patient selection, stratification and management of patient treatment, enabling healthcare to get highly sensitive, standardized, reliable results that support clinical development, regulatory approval and commercialization of novel drugs in the treatment of migraine and neuroinflammation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Primary Office
  • Aalborg
  • Denmark
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EMProS-Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view EMProS-Bio’s complete valuation and funding history, request access »

EMProS-Bio Executive Team (2)

Name Title Board Seat Contact Info
Meg Duroux Co-Founder
Parisa Gazerani Co-Founder
To view EMProS-Bio’s complete executive team members history, request access »

EMProS-Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Accelerace Accelerator/Incubator 000 0000 000000 0
To view EMProS-Bio’s complete investors history, request access »